DPM Blogs

What You Should Know About The ‘Lisfranc Fracture Equivalent’

11/30/10 | 5755 reads | 1 comments
I would like to use this blog to introduce a term/condition: the “Lisfranc fracture equivalent.” This new term identifies a patient who has a subtle ligamentous Lisfranc injury that is radiographically aligned within the midfoot keystone. This patient also has the uncommon stigmata of a Lisfranc fracture dislocation, which include: non-first interspace fleck fractures of the tarsometatarsal joints; lesser metatarsal neck fractures (often oblique); and/or a non-displaced cuboid injury/nutcracker fracture. Read More.

Ready To Train Or Ready To Practice? Redefining The Goals And Expectations Of Schools And Residency Programs

Kathleen Satterfield DPM FACFAOM
11/29/10 | 2454 reads | 6 comments
Here we are again. Another period of graduates outmatching the number of training programs until the powers that be gear up and produce more slots. Let “quality” be the key word this time please. Also, residency directors, keep in mind that this is the 21st century and let me introduce a concept: “the handoff.” You may have heard of it but apparently expectations are still mired back in the 1960s and 1970s. I hear it from colleagues around the country all of the time, even on these blogs. Read More.

How To Attain The Best Results With The Phenol And Alcohol Onychoplasty

Patrick DeHeer DPM FACFAS
11/24/10 | 5284 reads | 4 comments
While the phenol and alcohol onychoplasty is the most commonly performed procedure by podiatric physicians, it is also the one that is least written about. This is possibly because it is a relatively simple procedure that even the least surgically inclined podiatrist is comfortable performing. I have discovered three important tips for the partial phenol and alcohol procedure that have made a good procedure even better. For a video of my approach with this procedure, check out the following link ( http://bit.ly/aOpe47 ) at the PodiatryLIVE™ website. Read More.

What You Missed At The Association of Extremity Nerve Surgeons (AENS) Meeting

Stephen Barrett DPM FACFAS
11/19/10 | 3892 reads | 0 comments
I recently had a great dinner in Fort Worth, Texas with 20 individuals, most of whom hold an extreme passion for lower extremity peripheral nerve surgery. There were also a few whose “seed for nerve passion” was just planted. It is always great to have a mix of weathered peripheral nerve veterans with excited neophytes because they ask fresh questions. Read More.

Current Insights In Detecting Metatarsus Adductus

Ron Raducanu DPM FACFAS
11/15/10 | 4485 reads | 1 comments
Metatarsus adductus is a subject of wide discussion, even for those who do not see many pediatric patients. The reality is that metatarsus adductus can cause devastating long-term sequelae if one does not identify and treat it correctly.   Early detection is also something that seems to be lacking in the pediatric population as children are not very good historians when it comes to complaints of pain and rarely will notice that they have a deformity unless it impedes them from doing what they want to do.   Read More.

Looking Beyond The Patient’s Chief Complaint

Russell Volpe DPM
11/11/10 | 3408 reads | 0 comments
One of the things I learned early on in my career from my teachers and mentors in podiatric medicine is the importance of looking beyond the chief complaint when evaluating a patient’s feet. Read More.

Secrets To Navigating Hammertoe Surgery On The Fifth Toe

William Fishco DPM FACFAS
11/9/10 | 12761 reads | 3 comments
This blog is dedicated to the ultimate podiatry oxymoron: a simple hammertoe surgery of the fifth toe. When it comes to foot surgery, we all got our start working on toes. In school, we all learned the three etiologies of hammertoes: extensor substitution, flexor substitution and flexor stabilization. Based on those theories, we learned a surgical algorithm. Once we got into residency, we learned that nobody really used the "textbook" for making a decision on what to do surgically. Read More.

Will The FDA-Approved Ceftaroline Be Promoted To Podiatry?

Warren S. Joseph DPM FIDSA
11/8/10 | 4156 reads | 0 comments
As I expected and predicted in my previous blog, the FDA did not waste much time approving ceftaroline (Teflaro, Forest Laboratories) for complicated skin and skin structure infections (cSSSI). (See http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm231594.htm ). Read More.

Why A Sports Medicine Practice Is A Golden Opportunity

Doug Richie Jr. DPM FACFAS
11/5/10 | 3707 reads | 1 comments
Every day, I access a popular podiatric list serve and read numerous submissions from my colleagues who lament about their declining enthusiasm to continue practicing podiatric medicine. Many feel “helpless” as third party payors make regular cuts in reimbursement for services rendered. Others complain about the lack of ”parity” in training, scope of practice and acceptance in the community of podiatric physicians in comparison with our MD counterparts. Read More.